Tag: Multiple Sclerosis
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
SIR: ‘Liberation Therapy’ Ineffective As MS Treatment
Invasive procedure carries risk of complications, significant financial cost, researcher says
AAN: Certain Symptoms Predictive of Worsening MS
Fatigue, limited leg function tied to progressive disease
Better Stem Cell Tx Outcomes for Younger MS Patients
Results support additional trials of autologous hematopoietic stem cell transplantation
Ocrelizumab Targets Role of B Cells in Multiple Sclerosis
Studies show lower relapse rate in relapsing MS, lower rate of progression in primary progressive dz
Vitamin D in Pregnancy Might Help Prevent MS in Offspring
Infants born with low levels of vitamin D may be more likely to develop multiple sclerosis later in life
Alemtuzumab May Reverse Some Disability in Newly-Diagnosed MS
Alemtuzumab modifies disability measures favorably compared with SC IFN-β-1a
Physical Activity Does Not Appear to Lower MS Risk in Women
Study shows no benefit, but staying active can help ease disease symptoms
Laquinimod Appears Effective Against Multiple Sclerosis
Animal study indicates laquinimod slows disease progression, but human trials needed
Long-Term Benefit Seen for Early Treatment of MS Symptoms
Industry-funded study also found therapy doubled time until a relapse occurred
